Rumen bypass calcium salts of trans and polyunsaturated fatty acids
View Patent ↗Free-flowing unsaturated fatty acid calcium salts with a fatty acid content consisting essentially of (a) about 40 to about 95 wt % unsaturated C16–C22 fatty acids; (b) about 5 to about 60 wt % saturated C14–C22 fatty acids; and (c) no more than about 6 wt % moisture, insolubles and unsaponifiables; with no more than about 20 wt % in the form of glycerides; wherein about 40 to about 65 wt % of total product weight is of trans fatty acids and one or more fatty acids selected from C18:2 and C18:3 fatty acids and C20–C22 omega-3 and omega-6 fatty acids. Products with about 10 to about 65 wt % of total product weight of CLA's and one or more fatty acids selected from non-conjugated C18:2 and C18:3 fatty acids and C20–C22 omega-3 and omega-6 fatty acids are also disclosed.
1. A free-flowing unsaturated fatty acid calcium salt comprising a fatty acid content consisting essentially of (a) from about 40 to about 95% percent by weight of unsaturated C16–C22 fatty acids; (b) from about 5 to about 60% by weight of saturated C14–C22 fatty acids; and (c) no more than about 6% by weight of moisture, insolubles and unsaponifiables; with no more than about 20% by weight being in the form of glycerides; wherein from about 40 to about 65% by weight of the total product weight consists of trans fatty acids and one or more fatty acids selected from the group consisting of C18:2 fatty acids, C18:3 fatty acids, C20–22 omega-3 fatty acids and C20–22 omega-6 fatty acids.
2. The fatty acid calcium salt of claim 1 , wherein said trans fatty acids are present in an amount between about 25 and about 55% by weight of the total product weight.
3. The fatty acid calcium salt of claim 1 , comprising from about 5 to about 20% by weight of 1 or more fatty acids selected from the group consisting of C18:2 fatty acids, C18:3 fatty acids, C20–C22 omega-3 fatty acids, and C20–C22 omega-6 fatty acids.
4. The fatty acid calcium salt of claim 1 , comprising one or more C18:2 fatty acids selected from the group consisting of CLA's, C18:2 omega-3 fatty acids and C18:2 omega-6 fatty acids.
5. The fatty acid calcium salt of claim 1 , comprising either or both DHA and EPA.
6. The fatty acid calcium salt of claim 1 , comprising one or more C18:3 fatty acids.
7. The fatty acid calcium salt of claim 1 , comprising one or more omega-6 fatty acids.
8. The fatty acid calcium salt of claim 1 , comprising from about 0.1 to about 1.5 equivalents of calcium hydroxide relative to the fatty acid content.
9. A nutritional supplement composition comprising the fatty acid calcium salt of claim 1 .
10. A pet food product comprising the fatty acid calcium salt of claim 1 .
11. A free-flowing unsaturated fatty acid calcium salt comprising a fatty acid content consisting essentially of (a) from about 40 to about 95% by weight of unsaturated C16–C22 fatty acids; (b) from about 5 to about 60% by weight of saturated C14–C22 fatty acids; and (c) no more than about 6% by weight of moisture, insolubles and unsaponifiables; with no more than about 20% by weight being in the form of glycerides; wherein from about 10 to about 65% by weight of the total product weight consists of CLA's and one or more fatty acids selected from the group consisting of non-conjugated C18:2 fatty acids, C18:3 fatty acids, C20–C22 omega-3 fatty acids and C20–C22 omega-6 fatty acids.
12. The fatty acid calcium salt of claim 11 , wherein said CLA's are present in an amount between 7.5 and about 40% by weight of the total product weight.
13. The fatty acid calcium salt of claim 11 , comprising between about 7.5 and about 15% by weight of one or more fatty acids selected from the group consisting of non-conjugated C18:2 fatty acids, C18:3 fatty acids, C20–C22 omega-3 fatty acids and C20–C22 omega-6 fatty acids.
14. The fatty acid calcium salt of claim 11 , comprising one or more non-conjugated C18:2 fatty acids selected from the group consisting of C18:2 omega-3 fatty acids and C18:2 omega-6 fatty acids.
15. The fatty acid calcium salt of claim 11 , comprising either of both DHA and EPA.
16. The fatty acid calcium salt of claim 11 , comprising one or more C18:3 fatty acids.
17. The fatty acid calcium salt of claim 11 , comprising one or more omega-6 fatty acids.
18. The fatty acid calcium salt of claim 11 , comprising from about 0.1 to about 1.5 equivalents of calcium hydroxide relative to the fatty acid content.
19. A nutritional supplement composition comprising the fatty acid calcium salt of claim 11 .
20. The nutritional supplement composition of claim 19 , characterized in that said supplement is intended for human consumption.
21. A pet food product comprising the fatty acid calcium salt of claim 11 .